ACTIVE

PHARMACIE SAINT GUIDON

Financial year 2025 · Closed on 31/12/2025

Net result80,4 k €+3 409,8 %over 1 year
Gross margin153,4 k €+1 084,8 %over 1 year
Equity168,6 k €+71,7 %over 1 year
Workforce0,5 ETP

Identity

Source · BCE/KBO

PHARMACIE SAINT GUIDON is a Private company with limited liability incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht. It employs on average 0,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0822.189.321
Incorporation
12/01/2010
Legal form
Private company with limited liability
Registered office
Rue Saint Guidon 21
1070 Anderlecht · BruxellesSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Average workforce
0,5 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 17 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin153,4 k €12,9 k €32 k €8,5 k €35,9 k €
EBITDA121 k €12,6 k €31,4 k €8,2 k €35,4 k €
Operating result111,4 k €4,6 k €18,5 k €-5,6 k €19,5 k €
Net result80,4 k €2,3 k €11,6 k €-6,2 k €13,9 k €
Balance sheet
Equity168,6 k €98,2 k €95,9 k €84,3 k €90,5 k €
Total assets296,1 k €180,1 k €239,6 k €238,5 k €287,7 k €
Cash67,7 k €46,5 k €46,4 k €4,7 k €23,3 k €
Debts127,5 k €81,9 k €142,7 k €154,2 k €197,2 k €
Other
Workforce0,5 ETP––––

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

YAPHARM

Director · 0752.712.377

Represented by Aikar Yassine

Active

Ended mandates

YAPHARM

Director · since 01 janvier 2025 · 0752.712.377

Ended
PETER DUMOULIN

Administrator - manager · since 12 janvier 2010

Ended
GENEVIEVE VYNCKE

Mandate

Ended
PETER DUMOULIN

Mandate

Ended

Other companies at this address

Rue Saint Guidon 21 1070 Anderlecht
CompanyCBE no.
CA DENTAL● Active
1037.696.102

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202616/06/202507/06/202428/09/202307/07/202219/05/2021
General meeting21/08/202625/04/202526/04/202428/04/202329/04/202230/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202521/08/202631/08/2026FrenchPDF
Micro model31/12/202425/04/202516/06/2025FrenchPDF
Micro model31/12/202326/04/202407/06/2024FrenchPDF
Micro modelCorrection31/12/202228/04/202328/09/2023FrenchPDF
Micro model31/12/202228/04/202310/08/2023FrenchPDF
Micro model31/12/202129/04/202207/07/2022FrenchPDF
Micro model31/12/202030/04/202119/05/2021FrenchPDF
Micro model31/12/201924/04/202014/07/2020FrenchPDF
Micro model31/12/201826/04/201914/06/2019FrenchPDF
Abridged model31/12/201727/04/201825/05/2018FrenchPDF
Abridged model31/12/201628/04/201702/05/2017FrenchPDF
Abridged model31/12/201529/04/201626/05/2016FrenchPDF
Abridged model31/12/201424/04/201528/04/2015FrenchPDF
Abridged model31/12/201325/04/201408/05/2014FrenchPDF
Abridged model31/12/201226/04/201316/05/2013FrenchPDF
Abridged model31/12/201126/04/201221/05/2012FrenchPDF
Abridged model31/12/201029/04/201104/05/2011FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

YAPHARM

Director · 0752.712.377

Represented by Aikar Yassine

Active

Ended mandates

YAPHARM

Director · since 01 janvier 2025 · 0752.712.377

Ended
PETER DUMOULIN

Administrator - manager · since 12 janvier 2010

Ended
GENEVIEVE VYNCKE

Mandate

Ended
PETER DUMOULIN

Mandate

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/01/2025
    DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
    PDF
  • Capital / shares22/10/2010
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other21/01/2010
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202580,4 k €↑
  2. 2024
    Annual accounts 20242,3 k €↓
  3. 2023
    Annual accounts 202311,6 k €↑
  4. 2022
    Annual accounts 2022-6,2 k €↓
  5. 2021
    Annual accounts 202113,9 k €↓
  6. 2020
    Annual accounts 202036,8 k €↑
  7. 2019
    Annual accounts 2019-4,6 k €↓
  8. 2018
    Annual accounts 20188,1 k €↑
  9. 2017
    Annual accounts 2017-27,9 k €↓
  10. 2016
    Annual accounts 20168,4 k €↑
  11. 2015
    Annual accounts 2015-6,4 k €↓
  12. 2014
    Annual accounts 201414,8 k €↑
  13. 2013
    Annual accounts 201310,1 k €↓
  14. 2012
    Annual accounts 201232,5 k €↑
  15. 2011
    Annual accounts 201112,8 k €↑
  16. 2010
    Annual accounts 2010-4,2 k €
  17. 12/01/2010
    IncorporationPrivate company with limited liability